Search research articles
Contact Us
Filters
Showing results (1251-1260 of 1,489) with videos related to
Page
of 149
Sort By:
European Journal of Human Genetics : EJHG
|
June 23, 2005
PINK1, Parkin, and DJ-1 mutations in Italian patients with early-onset parkinsonism
Christine Klein, Ana Djarmati, Katja Hedrich, et al.
Cerebellum (London, England)
|
December 6, 2013
Consensus paper: pathological mechanisms underlying neurodegeneration in spinocerebellar ataxias
A Matilla-Dueñas, T Ashizawa, A Brice, et al.
NPJ Precision Oncology
|
October 29, 2025
Diversity of BRAF mutations in non-small cell lung cancer and implications on treatment
Kevin Lu, John Paul Shen, Fernando J Lopez-Diaz, et al.
Lancet (London, England)
|
October 2, 2012
Range of genetic mutations associated with severe non-syndromic sporadic intellectual disability: an exome sequencing study
Anita Rauch, Dagmar Wieczorek, Elisabeth Graf, et al.
European Journal of Human Genetics : EJHG
|
May 13, 2010
A total of 220 patients with autosomal dominant spastic paraplegia do not display mutations in the SLC33A1 gene (SPG42)
Nina A Schlipf, Christian Beetz, Rebecca Schüle, et al.
Neurobiology of Disease
|
April 5, 2012
Generation of a novel rodent model for DYT1 dystonia
Kathrin Grundmann, Nicola Glöckle, Giuseppina Martella, et al.
FEMS Microbiology Ecology
|
March 2, 2016
Determining threshold values for barcoding fungi: lessons from Cortinarius (Basidiomycota), a highly diverse and widespread ectomycorrhizal genus
Sigisfredo Garnica, Max Emil Schön, Kessy Abarenkov, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
March 6, 2026
Genomic Profiling of Epidermal Growth Factor Receptor Mutation-Positive Non-Small Cell Lung Cancer Post-Progression on First-Line Osimertinib: Phase II ORCHARD Study
Helena A Yu, Kwan Ho Tang, Aleksandra A Markovets, et al.
Cancer Research
|
October 15, 1996
Clinical experiences with magnetic drug targeting: a phase I study with 4'-epidoxorubicin in 14 patients with advanced solid tumors
A S Lübbe, C Bergemann, H Riess, et al.
Neurobiology of Disease
|
February 17, 2006
Selective striatal neuron loss and alterations in behavior correlate with impaired striatal function in Huntington's disease transgenic rats
Orsolya Kántor, Yasin Temel, Carsten Holzmann, et al.
Page
of 149
Search research articles
Search
Showing results (1251-1260 of 1,489) with videos related to
Sort By:
Page
of 149
European Journal of Human Genetics : EJHG
|
June 23, 2005
PINK1, Parkin, and DJ-1 mutations in Italian patients with early-onset parkinsonism
Christine Klein, Ana Djarmati, Katja Hedrich, et al.
Cerebellum (London, England)
|
December 6, 2013
Consensus paper: pathological mechanisms underlying neurodegeneration in spinocerebellar ataxias
A Matilla-Dueñas, T Ashizawa, A Brice, et al.
NPJ Precision Oncology
|
October 29, 2025
Diversity of BRAF mutations in non-small cell lung cancer and implications on treatment
Kevin Lu, John Paul Shen, Fernando J Lopez-Diaz, et al.
Lancet (London, England)
|
October 2, 2012
Range of genetic mutations associated with severe non-syndromic sporadic intellectual disability: an exome sequencing study
Anita Rauch, Dagmar Wieczorek, Elisabeth Graf, et al.
European Journal of Human Genetics : EJHG
|
May 13, 2010
A total of 220 patients with autosomal dominant spastic paraplegia do not display mutations in the SLC33A1 gene (SPG42)
Nina A Schlipf, Christian Beetz, Rebecca Schüle, et al.
Neurobiology of Disease
|
April 5, 2012
Generation of a novel rodent model for DYT1 dystonia
Kathrin Grundmann, Nicola Glöckle, Giuseppina Martella, et al.
FEMS Microbiology Ecology
|
March 2, 2016
Determining threshold values for barcoding fungi: lessons from Cortinarius (Basidiomycota), a highly diverse and widespread ectomycorrhizal genus
Sigisfredo Garnica, Max Emil Schön, Kessy Abarenkov, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
March 6, 2026
Genomic Profiling of Epidermal Growth Factor Receptor Mutation-Positive Non-Small Cell Lung Cancer Post-Progression on First-Line Osimertinib: Phase II ORCHARD Study
Helena A Yu, Kwan Ho Tang, Aleksandra A Markovets, et al.
Cancer Research
|
October 15, 1996
Clinical experiences with magnetic drug targeting: a phase I study with 4'-epidoxorubicin in 14 patients with advanced solid tumors
A S Lübbe, C Bergemann, H Riess, et al.
Neurobiology of Disease
|
February 17, 2006
Selective striatal neuron loss and alterations in behavior correlate with impaired striatal function in Huntington's disease transgenic rats
Orsolya Kántor, Yasin Temel, Carsten Holzmann, et al.
Page
of 149